John Franklin Fowler - Dec 14, 2021 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
CEO, Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
Dec 14, 2021
Transactions value $
$6,930
Form type
4
Date filed
12/15/2021, 05:05 PM
Next filing
Jan 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Options Exercise $6.93K +7.7K +2.14% $0.90 367K Dec 14, 2021 Direct
holding KZR Common Stock 3.75K Dec 14, 2021 By Trust
holding KZR Common Stock 38.5K Dec 14, 2021 By Montebello Holdings LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (Right to Buy) Options Exercise $0 -7.7K -8.52% $0.00 82.7K Dec 14, 2021 Common Stock 7.7K $0.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F2 Fully vested.